Developing biopolymers
for soft tissue repair

Glycologix, Inc. is an innovative clinical-stage biotechnology company developing locally delivered biopolymers aimed at the protection and repair of soft tissues. Our compounds mimic natural proteoglycans with high affinity to tissues starting with interstitial cystitis. This broadly applicable technology addresses multiple high value soft tissue indications, characterized by large patient populations and significant unmet medical needs, starting with our lead program, GLX-100, for interstitial cystitis/bladder pain syndrome (IC/BPS).